Year None202120202019201820172016 Date Latest Press Release May 9, 2019 Eiger BioPharmaceuticals Reports First Quarter 2019 Financial Results and Provides Business Update April 30, 2019 Eiger to Present at ChinaBio® Partnering Forum 2019 April 17, 2019 Eiger BioPharmaceuticals Announces Pricing of Public Offering of Common Stock April 17, 2019 Eiger BioPharmaceuticals Announces Proposed Public Offering of Common Stock April 15, 2019 Eiger BioPharmaceuticals Appoints Market Access, Public Policy Expert, and Biotech Veteran Amit K. Sachdev to Board of Directors April 11, 2019 Eiger Announces 36% Durable Virologic Response at 24 Weeks Post-Treatment with Peginterferon Lambda in Phase 2 LIMT HDV Study at The International Liver Congress™ 2019 March 26, 2019 Eiger BioPharmaceuticals to Participate in Conferences in April March 25, 2019 Eiger BioPharmaceuticals Announces Oral Presentation of Phase 2 PREVENT Study Results of Avexitide in Post-Bariatric Hypoglycemia at Endocrine Society Meeting (ENDO) 2019 March 20, 2019 Eiger BioPharmaceuticals Management Team to Present and Participate in China Healthcare Investment Conference 2019 March 14, 2019 Eiger BioPharmaceuticals Reports Fourth Quarter and Full Year 2018 Financial Results and Provides Business Update Pagination First page « first Previous page ‹ previous Page 1 Page 2 Page 3 Page 4 Current page 5 Page 6 Page 7 Page 8 Page 9 … Next page next › Last page last »
